A new study finds that cannabidiol (CBD) may offer relief from a common and challenging side effect of Parkinson’s treatment ...

Some individuals with schizophrenia who were treated with antibody suppressant drugs to treat biological disorders saw their ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

The Citizens Commission on Human Rights International (CCHR) warns that proposals to expand involuntary psychiatric commitment of the homeless will not ...

Serina Therapeutics advances POZ-VMAT2i into development for tardive dyskinesia: Huntsville, Alabama Thursday, July 31, 2025, 14:00 Hrs [IST] Serina Therapeutics, Inc. (Serina), a ...

Generic drugs had a "stable" performance in the second quarter, with global revenue down about 2% in local currency.

Medically reviewed by Nicholas R. Metrus, MD Tardive dyskinesia and dystonia are both neurological disorders that can affect your muscles and cause involuntary muscle contractions. Tardive dyskinesia, ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an ...

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025 ...

Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps.

A patient advocate discusses working while managing tardive dyskinesia and provides advice on requesting workplace accommodations.